The drug, still undergoing clinical trials in the U.S., seems to have the same side effects as the other COX-2 inhibitors, but in tests against morphine, ketorolac (Toradol) and a placebo, Dynastat was superior to morphine and the placebo and comparable to ketorolac in potency and duration.